Korean oncologists and endocrinologists said Tuesday that national health insurance coverage for Eli Lilly’s Retevmo ...
Nearly nine in 10 Korean adults believe weight-loss drugs, including prescription appetite suppressants, are widely misused ...
GC Cell said Tuesday it had discussed the potential introduction of its immune cell therapy Immuncell-LC in Türkiye and ...
MADRID, Spain -- By Hong Sook / Korea Biomedical Review correspondent -- Samsung Bioepis’ Keytruda biosimilar candidate SB27 ...
Korea’s biohealth exports rose 19.4 percent to a record $24.75 billion in the first nine months of 2026, led by a 31 percent ...
Dong-A ST said Tuesday it presented preclinical findings supporting the potential development of a topical formulation of ...
Siemens Healthineers Korea said Tuesday it is promoting its Enhanced Liver Fibrosis (ELF) blood test to Korean laboratory ...
Electrophysiologists shared clinical data and experience with Medtronic’s PulseSelect pulsed field ablation (PFA) system and ...
Celltrion said Tuesday its preliminary consolidated operating profit for the third quarter rose 74.3 percent from a year ...
Samyang Biopharm and CrossPoint Therapeutics signed a memorandum of understanding last Friday to develop next-generation gene ...
“Echocardiography is more than pressing a button to take pictures. It means reading blood flow and pressure in a constantly ...
Daewon Pharmaceutical said its oral semaglutide candidate DW5324 showed up to 3.14 times higher drug exposure than Novo’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results